Anacor Pharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
24 Jun 2016	Form 4: Hove Anders D, Director Returned 33,886 shares to the issuer ($3.36M) · Disposed of 91,596 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Shapiro Lucy, Director Returned 794 shares to the issuer ($78.8K) · Disposed of 12,409 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Rieflin William Jl, Director Returned 89,853 shares to the issuer ($8.92M) · Disposed of 4,403 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Leschly Mark, Director Returned 794 shares to the issuer ($78.8K) · Disposed of 103,096 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Leonard Keith R, Director Returned 794 shares to the issuer ($78.8K) · Disposed of 22,096 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Wierenga Wendall, Director Returned 794 shares to the issuer ($78.8K) · Disposed of 31,096 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Zane Lee, SVP and Chief Medical Officer Returned 44,194 shares to the issuer ($4.39M) · Disposed of 10,725 Performance Restricted Stock Units (Disposition to Issuer) · Disposed of 281,202 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Bell Graeme, Executive VP and CFO Returned 10,488 shares to the issuer ($1.04M) · Disposed of 17,012 Performance Restricted Stock Units (Disposition to Issuer) · Disposed of 54,092 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Berns Paul L, Director Returned 231,311 shares to the issuer ($23M) · Disposed of 27,474 Performance Restricted Stock Units (Disposition to Issuer) · Disposed of 551,888 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Sullivan Ryan T, EVP and General Counsel Returned 30,132 shares to the issuer ($2.99M) · Disposed of 12,600 Performance Restricted Stock Units (Disposition to Issuer) · Disposed of 85,983 Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2016	Form 4: Ippolito Vincent P, EVP & Chief Commercial Officer Returned 68,985 shares to the issuer ($6.85M) · Disposed of 11,930 Performance Restricted Stock Units (Disposition to Issuer) · Disposed of 114,699 Stock Option (right to buy) (Disposition to Issuer)
03 Jun 2016	Form 4: Bell Graeme, Executive VP and CFO Sold 751 shares ($74.6K)
24 May 2016	Form 4: Leonard Keith R, Director Received 9,000 shares by exercise or conversion ($128K) · Sold 9,000 shares ($897K)
18 May 2016	Form 4: Hove Anders D, Director Sold 353,881 shares ($35.2M)
29 Apr 2016	Form 4: Sullivan Ryan T, EVP and General Counsel Sold 3,125 shares ($207K)
15 Apr 2016	Form 4: Hove Anders D, Director Received 257,647 shares by conversion ($8M)
11 Apr 2016	Form 4: Hove Anders D, Director Sold 225,033 shares ($16M) · Sold 4,268 shares ($300K)
04 Apr 2016	Form 4: Rieflin William Jl, Director Received 89,000 shares by exercise or conversion ($741K)
22 Mar 2016	Form 4: Berns Paul L, Director Sold 37,500 shares ($2.26M)
04 Mar 2016	Form 4: Ippolito Vincent P, EVP & Chief Commercial Officer Sold 9,000 shares ($575K)

Comments